The ABI1 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the endogenous ABI1 gene has been disrupted, generating a loss-of-function model for investigating ABI1-mediated signaling and cytoskeletal regulation. This polyclonal product comprises a heterogeneous pool of edited cells, enabling the study of gene function in a population context relevant to many experimental paradigms without the need for clonal expansion.
The host cell line, HEK293T, is an adherent human embryonic kidney cell line stably expressing the SV40 large T antigen, which permits episomal amplification of plasmids bearing the SV40 origin. These cells are epithelial in origin, exhibit neuronal lineage markers, and are renowned for their high transfection efficiency and capacity for recombinant protein and virus production. Their robust metabolism and well-mapped signaling networks provide a versatile substrate for targeted genetic manipulation.
ABI1 encodes a scaffolding adaptor that couples Abl tyrosine kinases, including c-Abl and Bcr-Abl, to the WAVE regulatory complex, thereby activating the Arp2/3 complex and promoting actin filament branching. ABI1 directly interacts with WAVE1/2, NCKAP1, CYFIP1, and BRK1, and is regulated by upstream inputs from Src kinases, EGFR, and integrins. This molecular nexus coordinates lamellipodia formation, cell migration, and clathrin-mediated endocytosis, with downstream effects on Rac1 and Cortactin activity.
Loss of ABI1 in HEK293T cells disrupts the WAVE-Arp2/3 axis, leading to diminished lamellipodial protrusion, reduced cell motility, and impaired endocytic cargo internalization. The polyclonal knockout population recapitulates the genetic heterogeneity observed in tumor microenvironments, providing a physiologically relevant model for probing ABI1??s contributions to invasive phenotypes in malignancies such as glioblastoma and BCR-ABL1-driven leukemias.
These ABI1 knockout cells are ideally suited for mechanistic studies employing Western blot analysis of phospho-Abl and WAVE complex constituents, immunofluorescence-based visualization of F-actin reorganization, and functional migration assays including transwell invasion and scratch wound healing. Additional applications include live-cell imaging of lamellipodial dynamics, RT-qPCR profiling of downstream effector genes, and drug target validation for cytoskeletal modulators. For further information, please contact Ascent Research.
